CD40 ligand expression correlates with resolution of peritonitis and mononuclear cell recruitment

Peritoneal Dialysis International

Volumn 25, Issue 3, 2005, Pages 240-247

  Glik, Amir ^a   Mazar, Julia ^a   Rogachev, Boris ^a   Zlotnik, Moshe ^a   Douvdevani, Amos ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

CD154; CD40; Cell trafficking; Chemotaxis; Peritonitis

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DATA ANALYSIS; DETERIORATION; DISEASE COURSE; EFFLUENT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KINETICS; LEUKOCYTE; LEUKOCYTE COUNT; MACROPHAGE; MALE; MONONUCLEAR CELL; NONHUMAN; PERITONEAL DIALYSIS; PERITONEUM CELL; PERITONITIS; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL ANALYSIS; T LYMPHOCYTE;

EID: 19444376853     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080502500307     Document Type: Article

References (34)

1. Grewal IS, Ravell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16:111-35.
2. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000; 67:2-17.
3. Schonbeck U, Mach F, Libby P. CD154 (CD40 ligand). Int J Biochem Cell Biol 2000; 32:687-93.
4. Yamada A, Sayegh MH. The CD154-CD40 costimulatory pathway in transplantation. Transplantation 2002; 73(Suppl 1):S36-9.
5. Adawi A, Zhang Y, Baggs R, Rubin P, Williams J, Finkelstein J, et al. Blockade of CD40-CD40 ligand interactions protects against radiation-induced pulmonary inflammation and fibrosis. Clin Immunol Immunopathol 1998; 89: 222-30.
6. Howard LM, Miga AJ, Vanderlugt CL, Dal Canto MC, Laman JD, Noelle RJ, et al. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J Clin Invest 1999; 103: 281-90.
7. Lutgens E, Daemen MJ. CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc Med 2002; 12:27-32.
8. Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int 1997; 17:360-4.
9. Miyata T, Devuyst O, Kurokawa K, van Ypersele de Strihou C. Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int 2002; 61:375-86.
10. Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999; 19:517-25.
11. Basok A, Shnaider A, Man L, Chaimovitz C, Douvdevani A. CD40 is expressed on human peritoneal mesothelial cells and upregulates the production of interleukin-15 and RANTES. J Am Soc Nephrol 2001; 12:695-702.
12. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996; 97:2063-73.
13. MacDonald KPA, Nishioka Y, Lipsky PE, Thomas R. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest 1997; 100:2404-14.
14. Danese S, de la Motte C, Sturm A, Vogel JD, West GA, Strong SA, et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003; 124: 1249-64.
15. Kuwana M, Nomura S, Fujimura K, Nagasawa T, Muto Y, Kurata Y, et al. Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura. Blood 2004; 103:1229-36.
16. Hurst SM, Wilkinson TS, McLoughlin RM, Jones S, Horiuchi S, Yamamoto N, et al. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001; 14:705-14.
17. Yang X, Ye RG, Kong QY, Yang QQ, Gao Y, Zhong JH, et al. CD40 ligand expression on macrophages during peritonitis in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2000; 16:213-15.
18. Topley N. The cytokine network controlling peritoneal inflammation. Perit Dial Int 1995; 15(7, Suppl):S35-9; Discussion S39-40.
19. Topley N, Liberek T, Davenport A, Li FK, Fear H, Williams JD. Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int Suppl 1996; 56: S17-21.
20. Fault RJ. Peritoneal defenses against infection: winning the battle but losing the war? Semin Dial 2000; 13:47-53.
21. Yang X, Ye R, Kong Q, Yang Q, Dong X, Yu X. CD40 is expressed on rat peritoneal mesothelial cells and upregulates ICAM-1 production. Nephrol Dial Transplant 2004; 19:1378-84.
22. Koshy M, Berger D, Crow MK. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 1996; 98:826-37.
23. Devi BS, Van Noordin S, Krausz T, Davies KA. Peripheral blood lymphocytes in SLE-hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. J Autoimmun 1998; 11:471-5.
24. Balashov KE, Smith DR, Khoury SJ, Hafler DA, Weiner HL. Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+T cells via CD40 ligand. Proc Natl Acad Sci U S A 1997; 94:599-603.
25. Grewal IS, Xu J, Flavell RA. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 1995; 378:617-20.
26. Banchereau J, de Paoli P, Valle A, Garcia E, Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 1991; 251:70-2.
27. Grabstein KH, Maliszewski CR, Shanebeck K, Sato TA, Spriggs MK, Fanslow WC, et al. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2. J Immunol 1993; 150:3141-7.
28. Wu Y, Xu J, Shinde S, Grewal I, Henderson T, Flavell RA, et al. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. Curr Biol 1995; 5:1303-11.
29. Stout RD, Suttles J. The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 1996; 17: 487-92.
30. Stout RD, Suttles J, Xu J, Grewal IS, Flavell RA. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol 1996; 156:8-11.
31. Tsokos GC, Kammer GM. Molecular aberrations in human systemic lupus erythematosus. Mol Med Today 2000; 6:418-24.
32. Klinman DM, Steinberg AD. Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 1987; 165:1755-60.
33. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998; 394:200-3.
34. Kalled SL, Cutler AH, Datta SK, Thomas DW. Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J Immunol 1998; 160:2158-65.